People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, AI / ML, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. | — | Biotechnology | Series C | $143.0M | $392.5M | 2010 |
| LungLife AI, Inc. | — | AI / ML | Series B | $68.4M | $2.9M | 2009 |
| Affinity Biosensors Llc | — | Other | Series A | $63.0M | $4.3M | 2022 |
| CytomX Therapeutics, LLC | — | Other | Seed | $13.4M | $27.9M | 2009 |
| Vapore, Inc. | — | Other | Seed | $4.3M | $20.4M | 2009 |
| Agile RF Inc | — | Other | Pre-Seed | $2.5M | $11.6M | 2010 |
Michael E. Pfau at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael E. Pfau on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Pfau | 4 | 7 |
| Alan Heeger | 3 | 5 |
| Nancy Stagliano | 2 | 5 |
| Gary Wilcox | 2 | 4 |
| Frederick Gluck | 2 | 2 |
| David Anderson | 1 | 21 |
| Matthew Young | 1 | 7 |
| K. Leonard Judson | 1 | 7 |
| Elaine Jones | 1 | 6 |
| L. Robert Johnson | 1 | 5 |
| Paul Billings | 1 | 5 |
| Amit Munshi | 1 | 5 |
| Paul Anderson | 1 | 5 |
| Robert Balch | 1 | 4 |
| James McCullough | 1 | 3 |
| Sean McCarthy | 1 | 3 |
| Frederick W Gluck | 1 | 3 |
| Sara Barrington | 1 | 3 |
| Elaine V. Jones | 1 | 3 |
| George Holbrook | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.